These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4013237)

  • 41. [Attack on many vascular fronts. Atherothrombosis trouble seldom comes alone].
    MMW Fortschr Med; 2004; 146 Suppl 1():4-5. PubMed ID: 15493408
    [No Abstract]   [Full Text] [Related]  

  • 42. [Action of pyrithioxine combined with a vasodilator in patients with cerebral arteriosclerosis].
    Schlesinger P
    Rev Bras Med; 1972 Jan; 29(1):38-41. PubMed ID: 4552863
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical studies of the vasodilating activity of a new drug with adrenosympatholytic action].
    Melli A; Golinelli G
    Minerva Cardioangiol; 1967 Jun; 15(6):429-32. PubMed ID: 6056089
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical experimentation with a combination of substances having vasodilator effects on the cerebral circulation].
    Barbi G; Tallone G
    Minerva Med; 1967 Feb; 58(13):489-91. PubMed ID: 6021620
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of sudden deafness. Apropos of the parenteral and peroral administration of Cerebroxine].
    Vincent Y; Ermens F
    Acta Otorhinolaryngol Belg; 1983; 37(1):88-94. PubMed ID: 6613569
    [No Abstract]   [Full Text] [Related]  

  • 46. [The pentoxifylline and corglycon treatment of patients with circulatory encephalopathy against a background of atherosclerotic lesions of the major cerebral arteries].
    Ishchenko MM; Nechaĭ IeO; Korol'kov OS
    Lik Sprava; 1996; (1-2):143-5. PubMed ID: 9005077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Role of grandaxin in the treatment of functional gastrointestinal diseases].
    Osipenko MF; Khramov IuA; Makarova TA; Vdovenko EG
    Ter Arkh; 2000; 72(10):23-7. PubMed ID: 11220871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cyclospasmol 400 in cerebral circulation insufficiency].
    Warot P
    Lille Med; 1973; 18(7):842-4. PubMed ID: 4603446
    [No Abstract]   [Full Text] [Related]  

  • 49. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

  • 50. [Drug therapy in the rehabilitation of precocious geriatric complaints].
    Böhlau V
    Med Welt; 1975 Feb; 26(6):233-6. PubMed ID: 1121256
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of hypercholesterinemia with beta-pyridylcarbinol. II. Side effects and disscussion].
    Zöllner N; Gudenzi M
    Med Klin; 1966 Dec; 61(51):2036-40. PubMed ID: 5996572
    [No Abstract]   [Full Text] [Related]  

  • 52. [Cinnarizine and phosphatidyl choline in the treatment of cerebral arteriosclerotic pathology and arteriosclerosis of the lower extremities. Comparative study].
    Ciammaichella A; Solitro A; Arcuri P
    Minerva Cardioangiol; 1975 Mar; 23(3):191-200. PubMed ID: 1128771
    [No Abstract]   [Full Text] [Related]  

  • 53. [Serial angiographic evaluation of the effects of various vasoactive drugs on cerebral circulation in man].
    Bernini FP; Smaltino F
    Acta Neurol (Napoli); 1974 Mar; 29(2):170-84. PubMed ID: 4849693
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical and experimental experience with the nicotinic acid ester 7-oxyethyltheophylline].
    Fischbach R; Haas R
    Arzneimittelforschung; 1967 Mar; 17(3):313-7. PubMed ID: 5631222
    [No Abstract]   [Full Text] [Related]  

  • 55. The effects of cyclandelate on psychological test performance in patients with cerebral vascular insufficiency.
    Smith WL; Lowrey JB; Davis JA
    Curr Ther Res Clin Exp; 1968 Dec; 10(12):613-8. PubMed ID: 4972756
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experience with polysponin therapy of atherosclerosis].
    Milimovka ME; Konovalov MN; Rybnikov NI; Dimant MI
    Vrach Delo; 1971 Jan; (1):63-5. PubMed ID: 5576585
    [No Abstract]   [Full Text] [Related]  

  • 57. [On the use of cinnarizine dihydrochloride in the treatment of arteriosclerotic cerebropathy].
    Di Lorenzo S; Costagliola A; Lampasi D; Alfano S
    Minerva Cardioangiol; 1974 Dec; 22(12):867-70. PubMed ID: 4459730
    [No Abstract]   [Full Text] [Related]  

  • 58. [On the circulatory physiology and biochemistry of cerebral degeneration processes and influencing the behavior of patients with drug therapy].
    Cornu F
    Wien Klin Wochenschr; 1969 Jun; 81(23):426-31. PubMed ID: 5790194
    [No Abstract]   [Full Text] [Related]  

  • 59. [Place of combined cinnarizine-heptanol acefyllinate in treatment of vertigo and ear buzzing of vascular origin].
    Calvet J; Coll J; Stefani JM
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Feb; 18(2):127-30. PubMed ID: 4392741
    [No Abstract]   [Full Text] [Related]  

  • 60. [Changes in coagulographic indices of patients with cerebral atherosclerosis complicated by mental disorders during the treatment process].
    Pavlova SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(7):1016-9. PubMed ID: 7415719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.